Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SCI Ventures
New York, New York, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
SCI Ventures has assembled a portfolio of seven early-stage companies in its first year, catalyzing companies from preclinical proof-of-concept to first-in-human clinical trials. Notable successes include ONWARD Medical obtaining the first FDA approval for a chronic spinal cord injury therapy, and Axonis Therapeutics advancing from Harvard laboratory stage to a $115M Series A and impending clinical trial start. Several portfolio companies are in preclinical or IND-enabling stages, focusing on device, gene therapy, and small molecule innovation for functional restoration and cure-oriented SCI therapies.[1][6][7]
- Therapeutic areas
- Neurology
- Modalities
- DeviceGene therapySmall moleculeBiologic
- Industry
- Investors
02
Partnerships
Christopher & Dana Reeve FoundationWings for LifeInternational Spinal Research TrustPromobilia FoundationShepherd Center
Beyond the preview
Go deeper on SCI Ventures.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SCI Ventures.